4//SEC Filing
Matthews Judith M. 4
Accession 0000899243-19-003970
CIK 0001659323other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 11:29 AM ET
Size
5.9 KB
Accession
0000899243-19-003970
Insider Transaction Report
Form 4
Matthews Judith M.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-02-15+30,000→ 30,000 totalExercise: $5.80Exp: 2029-02-14→ Ordinary Shares (30,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of February 15, 2019 (the "Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date.
Documents
Issuer
Iterum Therapeutics plc
CIK 0001659323
Entity typeother
Related Parties
1- filerCIK 0001734033
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 11:29 AM ET
- Size
- 5.9 KB